Trial Profile

An Evaluation of Losmapimod in patients with Chronic Obstructive Pulmonary Disease (COPD) with systemic inflammation stratified using fibrinogen (EVOLUTION)

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 07 Sep 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

18 May 2019 This trial has been completed in United Kingdom, according to European Clinical Trials Database.
18 May 2016 Primary endpoint has not been met. (Endothelial function as measured by flow mediated dilatation), as per results presented at the 112th International Conference of the American Thoracic Society.
18 May 2016 Primary endpoint has not been met. (Vascular inflammation on FDG PET-CT), as per results presented at the 112th International Conference of the American Thoracic Society.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com